Disparities in receipt of medications for opioid use disorder among pregnant women

References

• Villapiano NL, Winkelman TN, Kozhimannil KB, Davis MM, Patrick SW. Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004 to 2013. JAMA Pediatr. 2017;171(2):194–196.
   PubMed Web of Science ®Google Scholar
• Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM, Patrick SW. Incidence and costs of neonatal abstinence syndrome among infants with Medicaid. Pediatrics. 2018;141(4):e20173520–2014.
   PubMed Web of Science ®Google Scholar
• Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014;123(5):997–1002.
   PubMed Web of Science ®Google Scholar
• Patrick SW, Barfield WD, Poindexter BB, Committee on Fetus and Newborn, Committee on Substance Use and Prevention. Neonatal opioid withdrawal syndrome. Pediatrics. 2020;146(5):e2020029074.
   PubMed Web of Science ®Google Scholar
• Pearce LA, Min JE, Piske M, et al. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study. BMJ. 2020;368:m772.
   PubMedGoogle Scholar
• Ordean A, Wong S, Graves L. No. 349-substance use in pregnancy. J Obstet Gynaecol Can. 2017;39(10):922–937.e922.
   PubMed Web of Science ®Google Scholar
• Zedler BK, Mann AL, Kim MM, et al. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Addiction. 2016;111(12):2115–2128.
   PubMed Web of Science ®Google Scholar
• Brogly SB, Hernández-Diaz S, Regan E, Fadli E, Hahn KA, Werler MM. Neonatal outcomes in a Medicaid population with opioid dependence. Am J Epidemiol. 2018;187(6):1153–1161.
   PubMed Web of Science ®Google Scholar
• United States Congress. S.524–Comprehensive Addiction and Recovery Act of 2016. Public Law No. 114-198. https://www.congress.gov/bill/114th-congress/senate-bill/524/text. Accessed November 13, 2020.
   Google Scholar
• Christie C, Baker C, Cooper R, Kennedy PJ, Madras B, Bondi P. The President’s Commission on Combating Drug Addiction and the Opioid Crisis: final Report. Washington, DC: Executive Office of the President, The White House; 2017.
   Google Scholar
• McBain RK, Dick A, Sorbero M, Stein BD. Growth and distribution of buprenorphine-waivered providers in the United States, 2007–2017. Ann Intern Med. 2020;172(7):504.
   PubMed Web of Science ®Google Scholar
• Kleinman RA. Comparison of driving times to opioid treatment programs and pharmacies in the US. JAMA Psychiatry. 2020;77(11):1163–1171.
   PubMed Web of Science ®Google Scholar
• Schiff DM, Nielsen T, Hoeppner BB, et al. Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts. JAMA Netw Open. 2020;3(5):e205734.
   PubMed Web of Science ®Google Scholar
• Patrick SW, Richards MR, Dupont WD, et al. Association of pregnancy and insurance status with treatment access for opioid use disorder. JAMA Netw Open. 2020;3(8):e2013456.
   PubMed Web of Science ®Google Scholar
• Patrick SW, Buntin MB, Martin PR, et al. Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states. Subst Abus. 2019;40(3):356–362.
   PubMed Web of Science ®Google Scholar
• Cooper LA, Roter DL, Carson KA, et al. The associations of clinicians' implicit attitudes about race with medical visit communication and patient ratings of interpersonal care. Am J Public Health. 2012;102(5):979–987.
   PubMed Web of Science ®Google Scholar
• Kaiser Family Foundation. Medicaid and CHIP income eligibility limits for pregnant women, 2003–2021. https://www.kff.org/medicaid/state-indicator/medicaid-and-chip-income-eligibility-limits-for-pregnant-women/. Published 2021. Accessed May 12, 2021.
   Google Scholar
• Piper JM, Mitchel EF, Jr., Snowden M, Hall C, Adams M, Taylor P. Validation of 1989 Tennessee birth certificates using maternal and newborn hospital records. Am J Epidemiol. 1993;137(7):758–768.
   PubMed Web of Science ®Google Scholar
• Piper JM, Ray WA, Griffin MR, Fought R, Daughtery JR, Mitchel E. Jr. Methodological issues in evaluating expanded Medicaid coverage for pregnant women. Am J Epidemiol. 1990;132(3):561–571.
   PubMed Web of Science ®Google Scholar
• Maalouf FI, Cooper WO, Stratton SM, et al. Positive predictive value of administrative data for neonatal abstinence syndrome. Pediatrics. 2019;143(1):e20174183.
   PubMed Web of Science ®Google Scholar
• Sanlorenzo LA, Cooper WO, Dudley JA, Stratton S, Maalouf FI, Patrick SW. Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure. Hosp Pediatr. 2019;9(8):569–575.
   PubMedGoogle Scholar
• Moore B, Barrett M. Case study: exploring how opioid-related diagnosis codes translate from ICD-9-CM to ICD-10-CM. US Agency for Healthcare Research and Quality. https://www.hcup-us.ahrq.gov/datainnovations/ICD-10CaseStudyonOpioid-RelatedIPStays042417.pdf. Published April 24, 2017. Accessed July 12, 2020.
   Google Scholar
• Ben J, Cormack D, Harris R, Paradies Y. Racism and health service utilisation: a systematic review and meta-analysis. PLOS One. 2017;12(12):e0189900.
   PubMed Web of Science ®Google Scholar
• Hansen HB, Siegel CE, Case BG, Bertollo DN, DiRocco D, Galanter M. Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City. J Behav Health Serv Res. 2013;40(3):367–377.
   PubMed Web of Science ®Google Scholar
• Sewell AA. The racism-race reification process: a mesolevel political economic framework for understanding racial health disparities. Sociol Race Ethn. 2016;2(4):402–432.
   Web of Science ®Google Scholar
• White K, Haas JS, Williams DR. Elucidating the role of place in health care disparities: the example of racial/ethnic residential segregation. Health Serv Res. 2012;47(3 Pt 2):1278–1299.
   PubMed Web of Science ®Google Scholar
• Sewell AA. Opening the black box of segregation. Race Real Estate. 2015;87:87–105.
   Google Scholar
• Williams DR, Lawrence JA, Davis BA. Racism and health: evidence and needed research. Annu Rev Public Health. 2019;40(1):105–125.
   PubMed Web of Science ®Google Scholar
• HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder [Press Release]. Washington, DC: United States Department of Health and Human Services; 2021.
   Google Scholar
• United States Department of Health and Human Services. 42 CFR part 8–medication assisted treatment for opioid use disorders. https://www.federalregister.gov/documents/2016/07/08/2016-16120/medication-assisted-treatment-for-opioid-use-disorders. Published July 8, 2016. Accessed January 5, 2021.
   Google Scholar
• Spetz J, Toretsky C, Chapman S, Phoenix B, Tierney M. Nurse practitioner and physician assistant waivers to prescribe buprenorphine and state scope of practice restrictions. JAMA. 2019;321(14):1407–1408.
   PubMed Web of Science ®Google Scholar
• Tennessee Code Annotated, Public Chapter 761, 2020.
   Google Scholar
• Tennessee Code Annotated, Public Chapter 771, 2020.
   Google Scholar
• Tennessee Division of TennCare. TennCare's opioid strategy. https://www.tn.gov/tenncare/tenncare-s-opioid-strategy.html. Published 2020. Accessed November 13, 2020.
   Google Scholar